The next 10 years see the combination antibody therapy

The next 10 years see the combination antibody therapy


The proportion of cancer-related deaths worldwide has increased significantly in recent years. The World Health Organization (WHO) estimates that more than 8 million people die from cancer each year and that there is likely to be a nearly 70% increase in new cancer cases over the next 20 years.

Request a free sample copy@

Chemotherapy is one of the specific treatments required for each form of cancer. As a result, Combination antibody therapy market is driven by rising cancer incidence and demand for chemotherapy drugs that can target cancer cells throughout the body.

The Chemotherapy/Antibodies segment in the North America region was valued at US$8,851.1 million by the end of 2016 and is expected to reach US$13,951.3 million by 2024. The chemotherapy/antibody segment of the North American combined antibody therapy market is expected to grow sales by a factor of 1.6 during the forecast period.

Contact sales for additional purchase assistance [email protected]

In contrast, in Latin America and the APAC regions, the market share of the chemotherapy/antibody segment is over 40%. In APAC, the chemotherapy/antibody segment was valued at over $2,000 million by the end of 2016 and is projected to reach nearly $6,000 million by 2024. The chemotherapy/antibody segment in APAC combination antibody therapy is expected to grow by 2.1 times the market in terms of revenue during the forecast period.

Customization request @

Market Segmentation : Combination antibody therapy market

Combination Antibody Therapy Market: Through combination

    • chemotherapy/antibodies
    • antibodies/antibodies
    • conjugated antibodies
    • Bispecific antibodies

Combination Antibody Therapy Market: By request

lung cancer



More to explorer

Understanding Key Factors in Accidents

Pedestrian Safety Statistics Pedestrian safety is an urgent concern worldwide, with over 1.3 million people dying in traffic accidents annually. Pedestrians account